Emerging biotechs and their investors are exploring partnerships with drug companies at much earlier stages. Experts at ...
On this week's episode, Joel Latham, President and CEO at Incannex Healthcare, talks about developing cannabinoid and psychedelic combination therapies for conditions as diverse as sleep apnea, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback